Bluejay Diagnostics, Inc. (BJDX) Stock Overview
Explore Bluejay Diagnostics, Inc.’s financial performance, market position, analyst ratings, and future outlook.
Bluejay Diagnostics, Inc. (BJDX)
Key Financials
Key Financials
Market Cap
2.1M
P/E Ratio
-0.30
EPS (TTM)
$-3.74
ROE
-1.44%
BJDX Stock Analysis & Investment Overview
Our comprehensive AI-powered analysis of Bluejay Diagnostics, Inc. (BJDX) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of C+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.
The current technical analysis reveals key indicators including an RSI of 68.13, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $244.33.
Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -0.30 and a market capitalization of 2.1M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.